Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: By 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT

Annals of Nuclear Medicine

Volumn 17, Issue 7, 2003, Pages 541-548

  Zhao, Chunlei ^a   Shuke, Noriyuki ^b   Okizaki, Atsutaka ^b   Yamamoto, Wakako ^b   Sato, Junichi ^b   Ishikawa, Yukio ^b   Ohta, Takafumi ^b   Hasebe, Naoyuki ^b   Kikuchi, Kenjiro ^b   Aburano, Tamio ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

123I 15 (p iodophenyl) 3 (R,S) methylpentadecanoic acid; 99mTc tetrofosmin; Dilated cardiomyopathy; Gated myocardial SPECT; Hypertrophic cardiomyopathy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; TETROFOSMIN TC 99M;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LINEAR REGRESSION ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 10744228138     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03006666     Document Type: Article

References (31)

1. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-329.
2. Zierler KL. Fatty acids as substrates for heart and skeletal muscle. Circ Res 1976; 38: 459-463.
3. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha- and beta-methyl-branched fatty acids. J Med Chem 1984; 27: 390-397.
4. Bax JJ, Knapp FF, Visser FC. Single-photon imaging of myocardial metabolism: the role of iodine-123 fatty acids and fluorine-18 deoxyglucose. In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, U.K.; Churchill Livingstone, 1998: 1497-1501.
5. Shimonagata T, Nishimura T, Uehara T, Hayashida K, Kumita S, Ohno A, et al. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy. Nucl Med Commun 1993; 14: 1005-1013.
6. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
7. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, et al. Myocardial emission computed ktomography with iodine-23-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13.
8. Kurata C, Kobayashi A, Yamazaki N. Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 1989; 30: 80-87.
9. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992; 19: 775-782.
10. 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy. Int J Cardiol 1996; 54: 51-59.
11. Narita M, Kurihara T. Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications. J Cardiol 1995; 25: 223-231.
12. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT. J Nucl Med 1997; 38: 1857-1863.
13. 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med 1999; 40: 471-478.
14. 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET. Nucl Med Commun 1995; 16: 336-343.
15. 123I-labelled beta-methyl-branched fatty acid wholebody scintigraphy and left ventricular ejection fraction in patients with ischaemic heart disease. Nucl Med Commun 1994; 15: 685-689.
16. 123I-BMIPP imaging in patients with vasospastic angina. KAKU IGAKU (Jpn J Nucl Med) 1996; 33: 599-606.
17. Shimizu M, Ino H, Okeie K, Emoto Y, Yamaguchi M, Yasuda T, et al. Cardiac dysfunction and long-term prognosis in patients with nonobstructive hypertrophic cardiomyopathy and abnormal (123)I-15-(p-lodophenyl)-3(R,S)-methylpentadecanoic acid myocardial scintigraphy. Cardiology 2000; 93: 43-49.
18. 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy. Ann Nucl Med 1996; 10: 225-230.
19. Kobayashi H, Nakata T, Han S, Takahashi N, Hashimoto A, Tsuchihashi K, et al. Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid. J Cardiol 1994; 24: 35-43.
20. Stevenson LW. Diseases of the myocardium. In: Bennette JC, Plum F, eds. Cecel Textbook of Medicine. Philadelphia, PA; W.B. Saunders, 1996: 327-336.
21. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N. et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37: 757-761.
22. 201Tl in patients with old myocardial infarction. KAKU IGAKU (Jpn J Nucl Med) 1994; 31: 927-933.
23. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050.
24. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12 Suppl: S39-44.
25. Yoshida S, Ito M, Mitsunami K, Kinoshita M. Improved myocardial fatty acid metabolism after coronary angioplasty in chronic coronary artery disease. J Nucl Med 1998; 39: 933-938.
26. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39: 266-271.
27. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995; 2: 317-326.
28. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664-671.
29. Meleca MJ, McGoron AJ, Gerson MC, Millard RW, Gabel M, Biniakiewicz D, et al. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia. J Nucl Med 1997; 38: 1847-1856.
30. 99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch. J Nucl Med 2003; 44: 33-39.
31. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzyl-guanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.